Fermentalg SA (ALGAE) AI Stock Analysis

5 Followers

Fermentalg SA

(Paris:ALGAE)

Select Model

Rating:44Neutral

Price Target:EUR 0.36▼(-9.60% Downside)

Action:upgraded

Date:10/09/26

The score is mainly influenced by poor financial performance with persistent losses and cash burn. Technical indicators add bearish pressure as price trades below moving averages, while valuation reflects typical biotech challenges from negative earnings.

Positive Factors

Revenue ExpansionThe substantial increase in revenue demonstrates meaningful commercial progress and broader market adoption of Fermentalg’s microalgae-based ingredients. Continued top-line growth can improve operating leverage over time, provided the company converts expanding sales into stronger margins and cash generation.

Negative Factors

Persistent UnprofitabilityFermentalg has not yet scaled its revenue base sufficiently to cover its cost structure, despite improved sales and gross margin. Persistent operating and net losses weaken financial resilience, constrain internally funded investment, and make future performance dependent on achieving a meaningful profitability inflection.

Fermentalg SA (ALGAE) vs. iShares MSCI France ETF (EWQ)

Market Cap: EUR 46.73M
Dividend Yield: ―
Average Volume (3M): 76.87K
Price to Earnings (P/E): -4.6
Beta (1Y): 0.91
Revenue Growth: 3.22%
EPS Growth: 24.05%
Country: France
Employees: 62
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Fermentalg SA Business Overview & Revenue Model

Company Description

Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve various i...

Fermentalg SA Financial Statement Overview

Summary

Fermentalg SA faces significant profitability challenges with a -70.5% net margin, negative operating cash flow of -€6.6M, and declining equity despite revenue growth and lower debt.

Income Statement

25Negative

Balance Sheet

40Negative

Cash Flow

30Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	13.20M	13.38M	11.50M	4.06M	7.65M	5.65M
Gross Profit	959.00K	2.29M	2.50M	536.00K	-828.00K	-675.00K
EBITDA	-7.90M	-6.32M	-9.99M	-10.49M	-7.19M	-8.91M
Net Income	-9.31M	-9.44M	-12.88M	-14.15M	-9.87M	-6.85M
Balance Sheet
Total Assets	43.31M	36.44M	51.14M	50.24M	57.54M	60.88M
Cash, Cash Equivalents and Short-Term Investments	10.79M	6.62M	20.58M	11.16M	15.90M	26.01M
Total Debt	3.93M	5.02M	12.60M	15.35M	11.02M	9.61M
Total Liabilities	11.40M	11.26M	18.39M	19.40M	15.56M	13.87M
Stockholders Equity	31.91M	25.18M	32.76M	30.85M	41.98M	47.00M
Cash Flow
Free Cash Flow	-7.69M	-8.13M	-2.00M	-11.18M	-13.72M	-12.55M
Operating Cash Flow	-6.27M	-6.59M	-531.00K	-8.69M	-8.24M	-7.66M
Investing Cash Flow	-938.00K	-1.75M	-1.13M	-1.76M	-7.29M	-4.75M
Financing Cash Flow	5.14M	-5.62M	11.08M	5.71M	5.42M	26.58M

Fermentalg SA Technical Analysis

Technical Analysis SentimentPositive

Last Price0.40

Price Trends

50DMA0.42Negative

100DMA0.45Negative

200DMA0.47Negative

Market Momentum

MACD-0.01Negative

RSI48.63Neutral

STOCH60.83Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALGAE, the sentiment is Positive. The current price of 0.40 is above the 20-day moving average (MA) of 0.39, below the 50-day MA of 0.42, and below the 200-day MA of 0.47, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 48.63 is Neutral, neither overbought nor oversold. The STOCH value of 60.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:ALGAE.

Fermentalg SA Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

FR:ALGAE against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FR:ALPAT	60Neutral	EUR 4.52M	6.59	―	―	10.59%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
FR:ALGAE	44Neutral	EUR 46.73M	-4.56	-32.62%	―	3.22%	24.05%
FR:ALVAL	43Neutral	EUR 21.64M	-2.09	-84.11%	―	183.47%	57.15%

* Healthcare Sector Average

Performance Comparison

FR:ALGAE and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
FR:ALGAE	Fermentalg SA	0.40	-0.06	-13.91%
FR:ALVAL	Valbiotis SA	0.61	0.06	11.82%
FR:ALPAT	Plant Advanced Technologies SA	3.98	-4.32	-52.05%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 09, 2026

Fermentalg SA AI Stock Analysis